Metastatic Prostate Cancer Treated by Flutamide versus Cyproterone Acetate: Final Analysis of the “European Organization for Research and Treatment of Cancer” (EORTC) Protocol 30892

This publication has 11 references indexed in Scilit:

• Prostate cancer treated by anti-androgens: is sexual function preserved?
  British Journal of Cancer, 2000
• Endocrine treatment of prostate cancer — recent developments and the future. Part 1: maximal androgen blockade, early vs delayed endocrine treatment and side‐effects
  BJU International, 1999
• Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years
  Urology, 1998
• Are non-steroidal anti-androgens appropriate as monotherapy in advanced prostate cancer?
  European Urology, 1998
• The Final Analysis of the EORTC Genito-Urinary T ract Cancer Co-Operative Group Phase III Clinical Trial (Protocol 30805) Comparing Orchidectomy, Orchidectomy plus Cyproterone Acetate and Low Dose Stilboestrol in the Management of Metastatic Carcinoma of the Prostate
  European Urology, 1995
• A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
  The Annals of Statistics, 1988
• Flutamide versus Stilboestrol in the Management of Advanced Prostatic Cancer: A Controlled Prospective Study
  British Journal of Urology, 1988
• Comparison of Diethylstilbestrol, Cyproterone Acetate and Medroxyprogesterone Acetate in the Treatment of Advanced Prostatic Cancer: Final Analysis of a Randomized Phase III Trial of the European Organization for Research on Treatment of Cancer Urological Group
  Journal of Urology, 1986
• Cardiovascular Side Effects of Diethylstilbestrol, Cyproterone Acetate, Medroxyprogesterone Acetate and Estramustine Phosphate Used for the Treatment of Advanced Prostatic Cancer: Results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762
  Journal of Urology, 1986
• Treatment of Advanced Prostatic Cancer with Parenteral Cyproterone Acetate: A Phase III Randomised Trial*
  British Journal of Urology, 1980